Literature DB >> 35821480

Bioluminescent Tracking of Human Induced Pluripotent Stem Cells In Vitro and In Vivo.

Toshinobu Nishimura1,2, Kouta Niizuma1,2,3, Hiromitsu Nakauchi4,5,6.   

Abstract

The discovery and development of induced pluripotent stem cells (iPSCs) opened a novel venue for disease modeling, drug discovery, and personalized medicine. Additionally, iPSCs have been utilized for a wide variety of research and clinical applications without immunological and ethical concerns that arise from using embryonic stem cells. Understanding the in vivo behavior of iPSCs, as well as their derivatives, requires the monitoring of their localization, proliferation, and viability after transplantation. Bioluminescence imaging (BLI) gives investigators a non-invasive and sensitive means for spatio-temporal tracking in vivo. For scientists working within the field of iPSCs, this protocol provides a walk-through on how to conduct in vitro and in vivo experiments with an iPSCs constitutively expressing luciferase.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bioluminescence imaging (BLI); Luciferase; Pluripotent stem cell; Teratoma

Mesh:

Substances:

Year:  2022        PMID: 35821480     DOI: 10.1007/978-1-0716-2453-1_22

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

Review 1.  Clinical hurdles for the transplantation of cardiomyocytes derived from human embryonic stem cells: role of molecular imaging.

Authors:  Rutger-Jan Swijnenburg; Koen Ea van der Bogt; Ahmad Y Sheikh; Feng Cao; Joseph C Wu
Journal:  Curr Opin Biotechnol       Date:  2006-12-29       Impact factor: 9.740

2.  Sufficiency for inducible Caspase-9 safety switch in human pluripotent stem cells and disease cells.

Authors:  Toshinobu Nishimura; Haojun Xu; Masayuki Iwasaki; Daiki Karigane; Brandon Saavedra; Yusuke Takahashi; Fabian P Suchy; Shinichiro Monobe; Renata M Martin; Manami Ohtaka; Mahito Nakanishi; Scott R Burrows; Michael L Cleary; Ravindra Majeti; Akira Shibuya; Hiromitsu Nakauchi
Journal:  Gene Ther       Date:  2020-07-23       Impact factor: 5.250

3.  Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration.

Authors:  Michiko Mandai; Akira Watanabe; Yasuo Kurimoto; Yasuhiko Hirami; Chikako Morinaga; Takashi Daimon; Masashi Fujihara; Hiroshi Akimaru; Noriko Sakai; Yumiko Shibata; Motoki Terada; Yui Nomiya; Shigeki Tanishima; Masahiro Nakamura; Hiroyuki Kamao; Sunao Sugita; Akishi Onishi; Tomoko Ito; Kanako Fujita; Shin Kawamata; Masahiro J Go; Chikara Shinohara; Ken-Ichiro Hata; Masanori Sawada; Midori Yamamoto; Sachiko Ohta; Yasuo Ohara; Kenichi Yoshida; Junko Kuwahara; Yuko Kitano; Naoki Amano; Masafumi Umekage; Fumiyo Kitaoka; Azusa Tanaka; Chihiro Okada; Naoko Takasu; Seishi Ogawa; Shinya Yamanaka; Masayo Takahashi
Journal:  N Engl J Med       Date:  2017-03-16       Impact factor: 91.245

4.  In vivo selection of genetically modified erythroid cells using a jak2-based cell growth switch.

Authors:  Shengming Zhao; Michael A Weinreich; Kenji Ihara; Robert E Richard; C Anthony Blau
Journal:  Mol Ther       Date:  2004-09       Impact factor: 11.454

5.  Efficient Adhesion Culture of Human Pluripotent Stem Cells Using Laminin Fragments in an Uncoated Manner.

Authors:  Takamichi Miyazaki; Takehisa Isobe; Norio Nakatsuji; Hirofumi Suemori
Journal:  Sci Rep       Date:  2017-01-30       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.